ADVANCED GASTRIC CANCER
Clinical trials for ADVANCED GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTRIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug duo targets Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests two drugs together—disitamab vedotin and tucatinib—in people with advanced breast or stomach cancers that have a protein called HER2. The goal is to see if the combination is safe and shrinks tumors. About 172 participants will take part.
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New injection could spare cancer patients from repeated belly drains
Symptom relief OngoingThis Phase 3 trial tests a drug called M701, given as an injection into the belly, to see if it can reduce the need for draining fluid in people with malignant ascites from advanced stomach, colorectal, or ovarian cancer. About 312 participants will either receive M701 plus drain…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE3 • Sponsor: Wuhan YZY Biopharma Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC